Cabot CORP 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NYSE
CBT
Cabot CORPCabot Corporation has announced the pricing of a $350 million offering of 4.950% notes due 2029, with an expected closing date of August 21, 2026.
NYSE
CBT
Cabot CORPCabot Corporation reported third quarter fiscal year 2026 results with diluted EPS of $0.12 and adjusted EPS of $1.67, driven by strong Performance Chemicals segment performance, while facing challenges in Reinforcement Materials.
NYSE
CBT
Cabot CORPCabot Corporation announced a planned leadership transition, with President and CEO Sean Keohane retiring effective September 30, 2026, and Erica McLaughlin appointed as his successor.
NYSE
CBT
Cabot CORPCabot Corporation has entered into a new $1.3 billion unsecured revolving credit agreement, replacing its previous credit lines and providing flexibility for general corporate purposes.
NYSE
CBT
Cabot CORPCabot Corporation announced its second quarter fiscal year 2026 results, reporting diluted EPS of $1.27 and adjusted EPS of $1.61, while also increasing its quarterly dividend by 5%.
NYSE
CBT
Cabot CORPCabot Corporation's annual meeting saw stockholders elect three directors, approve executive compensation, and ratify Deloitte & Touche LLP as auditors.
NYSE
CBT
Cabot CORPCabot Corporation reported first-quarter fiscal year 2026 Adjusted EPS of $1.53, a 13% year-over-year decrease, despite strong performance in its Battery Materials product line and a new multi-year supply agreement with PowerCo SE.
NYSE
CBT
Cabot CORPCabot Corporation announces board rebalancing efforts, including director term adjustments for Juan Enriquez, William C. Kirby, and Thierry Vanlancker, ahead of the 2026 Annual Meeting.
NYSE
CBT
Cabot CORPCabot Corporation announced its fiscal year 2025 results, reporting a 3% increase in Adjusted EPS to $7.25, while projecting a lower Adjusted EPS range of $6.00 to $7.00 for fiscal year 2026 due to macroeconomic and trade uncertainties.
NYSE
CBT
Cabot CORPCabot Corporation reported third quarter fiscal 2025 results with diluted EPS of $1.86 and adjusted EPS of $1.90, alongside strong operating cash flow despite a challenging demand environment.
NYSE
CBT
Cabot CORPCabot Corporation announced the retirement of Executive Vice President Hobart C. Kalkstein and the appointment of Matthew Wood as his successor in the Reinforcement Materials Segment, effective June 15, 2025, with Kalkstein remaining in an advisory role until January 5, 2026.
NYSE
CBT
Cabot CORPCabot Corporation reports a 7% increase in Adjusted EPS for the second quarter of fiscal year 2025, driven by strong performance in the Performance Chemicals segment.
NYSE
CBT
Cabot CORPCabot Corporation held its annual meeting of stockholders on March 13, 2025, and all proposals were approved.
NYSE
CBT
Cabot CORPCabot Corporation announces its first quarter fiscal year 2025 results, highlighting a 13% increase in Adjusted EPS compared to the same quarter in the prior year.
NYSE
CBT
Cabot CORPCabot Corporation outlined its strategic vision and financial targets for the next three years, building on its 'Creating for Tomorrow' strategy.
NYSE
CBT
Cabot CORPCabot Corporation announced its fourth quarter and fiscal year 2024 results, highlighting a 31% increase in adjusted EPS for the year and exceeding its 2021 Investor Day targets.
NYSE
CBT
Cabot CORP8-K: Cabot Corporation Reports Strong Third Quarter Fiscal 2024 Results, Raises Full-Year EPS Guidance
Cabot Corporation announced a 35% year-over-year increase in adjusted EPS for the third quarter of fiscal year 2024, driven by strong performance in both Reinforcement Materials and Performance Chemicals segments.
NYSE
CBT
Cabot CORPCabot Corporation has elected Thierry Vanlancker to its Board of Directors and appointed him to the Audit Committee, effective July 12, 2024.
NYSE
CBT
Cabot CORPCabot Corporation reported a significant increase in adjusted earnings per share and raised its full-year guidance, driven by strong performance in its Reinforcement Materials segment.
NYSE
CBT
Cabot CORPCabot Corporation held its annual meeting on March 7, 2024, where stockholders elected directors, approved executive compensation, adopted a director plan, and ratified the appointment of auditors.
NYSE
CBT
Cabot CORPCabot Corporation announced a strong start to fiscal year 2024, with adjusted EPS of $1.56, a 59% increase year-over-year, driven by robust performance in both Reinforcement Materials and Performance Chemicals segments.